Tailored immunotherapy cocktails show promise for tough stomach cancers
NCT ID NCT04739202
First seen Jun 10, 2026 · Last updated Jun 15, 2026 · Updated 2 times
Summary
This study tested whether matching immunotherapy drugs to the genetic makeup of a person's stomach cancer could improve treatment. It involved 54 adults whose cancer had returned or spread after standard chemotherapy. Researchers used tumor genetics to assign one of two immunotherapy combinations, aiming to see if this personalized approach could shrink tumors better than current options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aphm - Hopital La Timone
Marseille, 13385, France
-
Aphp - Hopital Pitie Salpetriere
Paris, 75013, France
-
Aphp - Hopital Saint-Louis
Paris, 75010, France
-
Bordeaux - Hopital Haut-Leveque
Pessac, 33604, France
-
Dijon - Centre Georges-Francois Leclerc
Dijon, 21000, France
-
Hcl - Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
Hcl - Hopital Edouard Herriot
Lyon, 69003, France
-
Toulouse - Iuct Rangueil-Larrey
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.